公司資料
Benitec Biopharma 股價、新聞與催化劑
- 股票代碼:
- BNTC
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Australia and listed in the U
股票表現
11.36 USD (+2.90%)
收盤價
最後更新: 2026年9月17日
363M USD
市值
股價為何變動
截至 2026年9月17日，BNTC 上漲 2.90%，收於 $11.36。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Benitec Biopharma is a gene-silencing biotechnology company focused on DNA-directed RNA interference and genetic medicine. Its story is built around platform science that aims to durably suppress disease-causing genes.
所在地與產業分類
Benitec is headquartered in Australia and listed in the U.S. market. It sits in gene therapy and genetic medicine biotechnology.
商業模式特徵
The business depends on translational validation, clinical milestones, and the ability to keep a narrow platform funded. Investors watch early data and strategic collaborations.
生技產業定位
Benitec occupies a gene-silencing niche within biotech. The stock is driven by whether the platform can prove durable and differentiated genetic medicine potential.
未來催化劑
- The next few months for Benitec Biopharma are centered on BB-301. The latest company update points to continued work around BB-301 and the next company-specific development update. If that progress holds, the program should stay on the radar through the rest of the quarter.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。